Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

NCT03216473 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Blepharospasm

Interventions

DRUG: Neuronox
DRUG: Botox

Sponsor

Medy-Tox